I'm LongbridgeAI, I can summarize articles.Neil Peterson, Chief Operating Officer at Merit Medical Systems (NASDAQ:MMSI), sold 7,500 shares worth $678,360 on August 25, as disclosed in an SEC Form 4 filing. The transaction occurred while MMSI shares were trading at $91.09, down 1.66%. This insider sale is part of routine reporting requirements for corporate officers.
Neil Peterson, Chief Operating Officer at Merit Medical Systems (NASDAQ:MMSI), disclosed an insider sell on August 25, according to a recent SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Peterson sold 7,500 shares of Merit Medical Systems. The total transaction amounted to $678,360.
As of Wednesday morning, Merit Medical Systems shares are down by 1.66%, currently priced at $91.09.
About Merit Medical Systems
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Breaking Down Merit Medical Systems's Financial Performance
Revenue Growth: Merit Medical Systems's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2026, the company achieved a revenue growth rate of approximately 9.51%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Key Profitability Indicators:
- Gross Margin: The company shows a low gross margin of 51.37%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
- Earnings per Share (EPS): With an EPS below industry norms, Merit Medical Systems exhibits below-average bottom-line performance with a current EPS of 0.65.
Debt Management: With a below-average debt-to-equity ratio of 0.49, Merit Medical Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyzing Market Valuation:
- Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 37.49, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
- Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 3.46 suggests overvaluation in the eyes of investors, considering sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): At 16.05, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Why Insider Activity Matters in Finance
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
The Insider's Guide to Important Transaction Codes
Taking a closer look at transactions, investors often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Merit Medical Systems's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.